- Home
- CXDO vs PRQR Comparison
CXDO vs PRQR Comparison
Compare CXDO & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CXDO
- PRQR
- Stock Information
- Founded
- CXDO 1995
- PRQR 2012
- Country
- CXDO United States
- PRQR Netherlands
- Employees
- CXDO N/A
- PRQR N/A
- Industry
- CXDO Telecommunications Equipment
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- CXDO Telecommunications
- PRQR Health Care
- Exchange
- CXDO Nasdaq
- PRQR Nasdaq
- Market Cap
- CXDO 198.8M
- PRQR 232.8M
- IPO Year
- CXDO 1998
- PRQR 2014
- Fundamental
- Price
- CXDO $6.65
- PRQR $2.06
- Analyst Decision
- CXDO Strong Buy
- PRQR Strong Buy
- Analyst Count
- CXDO 4
- PRQR 8
- Target Price
- CXDO $8.75
- PRQR $8.88
- AVG Volume (30 Days)
- CXDO 117.1K
- PRQR 368.1K
- Earning Date
- CXDO 11-05-2025
- PRQR 11-06-2025
- Dividend Yield
- CXDO N/A
- PRQR N/A
- EPS Growth
- CXDO 13.31
- PRQR N/A
- EPS
- CXDO 0.11
- PRQR N/A
- Revenue
- CXDO $64,476,000.00
- PRQR $20,129,184.00
- Revenue This Year
- CXDO $13.46
- PRQR N/A
- Revenue Next Year
- CXDO $11.81
- PRQR N/A
- P/E Ratio
- CXDO $60.99
- PRQR N/A
- Revenue Growth
- CXDO 13.10
- PRQR 8.65
- 52 Week Low
- CXDO $3.75
- PRQR $1.07
- 52 Week High
- CXDO $7.34
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- CXDO 56.75
- PRQR 42.63
- Support Level
- CXDO $6.37
- PRQR $1.91
- Resistance Level
- CXDO $6.85
- PRQR $2.50
- Average True Range (ATR)
- CXDO 0.30
- PRQR 0.16
- MACD
- CXDO 0.01
- PRQR -0.04
- Stochastic Oscillator
- CXDO 58.75
- PRQR 25.42
About CXDO Crexendo Inc.
Crexendo Inc is a provider of cloud communications, UCaaS, call centers, collaboration services, and other cloud business services. The company operates through two segments: Cloud telecommunications and Software Solutions. Its cloud telecommunications segment offers hardware, software, and unified communication solutions for businesses using IP or cloud technology over any high-speed Internet connection. The Software Solutions segment is involved in revenue generation from software licenses, software maintenance support, and professional services. It generates subscription and maintenance support revenue from customer support and other supportive services. The company offers warranties on its products. It derives a majority of its revenue from the Cloud telecommunications segment.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.